Fluxergy

Fluxergy

Portable diagnostic platform for rapid tests

Overview

Fluxergy creates a portable diagnostic platform that lets healthcare providers, veterinarians (including equine), and food-safety teams run multiple diagnostic tests on a single device, delivering rapid results at point-of-care. The system combines the device with disposable test kits to perform various tests, from molecular assays like COVID-19 to other health and safety checks, and is designed for fast, on-site decision-making. Fluxergy differentiates itself by offering industry-specific applications and a scalable, end-to-end solution (device plus kits) that targets diverse PoC settings, backed by partnerships and validated through collaborations with institutions such as Mass General Brigham. The company aims to expand production and adoption to set new benchmarks in how quickly and reliably laboratory testing can be done in real-world environments.

About Fluxergy

Simplify's Rating
Why Fluxergy is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$49.5M

Headquarters

Irvine, California

Founded

2011

Get referred to Fluxergy

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • NIH collaboration advanced in January 2025, with clinical trials targeted for 2025.
  • Fluxergy reported over 100,000 test cartridges manufactured by July 2026.
  • The Irvine expansion and new assay launches support broader European and veterinary sales.

What critics are saying

  • Headcount fell from 125 in 2023 to 82 in March 2026, signaling contraction.
  • Fluxergy still lacks FDA EUA for its core platform, limiting U.S. revenue conversion.
  • If NIH-backed STI trials slip past 2026, the company risks another commercialization stall.

What makes Fluxergy unique

  • Fluxergy's all-in-one analyzer compresses PCR, point-of-care, and sample prep into one platform.
  • NIH NIAID selected Fluxergy in 2024 for Diagnostics Development Services, signaling technical credibility.
  • Its veterinary and human infectious-disease menus create cross-market reuse across labs and clinics.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$49.5M

Below

Industry Average

Funded Over

3 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Below Average

Industry standards

$50M
$40M
Figma
$50M
Medium
$62M
SeatGeek
$100M
Oura

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-1%

2 year growth

-7%
Orange County Business Journal
Jan 6th, 2025
Fluxergy Partners with National Institutes of Health

Fluxergy partners with National Institutes of Health.

Fluxergy
Oct 5th, 2023
Fluxergy Launches New In-House Streptococcus equi ss equi Rapid PCR Assay

Fluxergy started its commercial launch of its in-house PCR platform in late 2022 and is now being used in over 80 veterinary labs and referral hospitals in the US, Canada and EU.

PR Newswire
Oct 2nd, 2023
Fluxergy Launches New In-House Streptococcus Equi Ss Equi Rapid Pcr Assay

"We are proud to offer an on-site solution and comprehensive laboratory training that can make a difference in how care providers navigate preventative and responsive pathogen testing.". .

Fluxergy
Jul 2nd, 2020
FluxErgy LLC. partnered with Mass General Brigham on Jul 2nd 20'.

IRVINE, CA., July 2, 2020 – California-based Fluxergy will work with Mass General Brigham (MGB), a major health system in Massachusetts, to further evaluate Fluxergy’s innovative Research Use Only (RUO) COVID-19 testing platform, designed to deliver accurate PCR test results in under one hour.

Fluxergy
Jun 30th, 2020
FluxErgy LLC. partnered with University of California - San Diego on Mar 1st 20'.

In March, Fluxergy announced that it was similarly working with a team at the University of California, San Diego, to evaluate its system for COVID-19 testing.

Recently Posted Jobs

Sign up to get curated job recommendations

Fluxergy is Hiring for 9 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →